Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Hepatic gluconeogenesis is absolutely required for survival during prolonged fasting or starvation, but is inappropriately activated in diabetes mellitus. Glucocorticoids and glucagon have strong gluconeogenic actions on the liver. In contrast, insulin suppresses hepatic gluconeogenesis. Two components known to have important physiological roles in this process are the forkhead transcription factor FOXO1 (also known as FKHR) and peroxisome proliferative activated receptor-gamma co-activator 1 (PGC-1alpha; also known as PPARGC1), a transcriptional co-activator; whether and how these factors collaborate has not been clear. Using wild-type and mutant alleles of FOXO1, here we show that PGC-1alpha binds and co-activates FOXO1 in a manner inhibited by Akt-mediated phosphorylation. Furthermore, FOXO1 function is required for the robust activation of gluconeogenic gene expression in hepatic cells and in mouse liver by PGC-1alpha. Insulin suppresses gluconeogenesis stimulated by PGC-1alpha but co-expression of a mutant allele of FOXO1 insensitive to insulin completely reverses this suppression in hepatocytes or transgenic mice. We conclude that FOXO1 and PGC-1alpha interact in the execution of a programme of powerful, insulin-regulated gluconeogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is a key regulator of mitochondrial biogenesis and respiration [27] that plays a critical role in the control of metabolism and energy homeostasis [28-30].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [30]
In the citing paper
“hepatic gluconeogenesis was suppressed, as witnessed by decreased expression of the FoxO1-regulated genes phosphoenolpyruvate carboxykinase (Pepck) and glucose-6-phosphatase (G6P) [72].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [72]
Citations
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Self-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Self-citationCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“In contrast, insulin suppresses hepatic gluconeogenesi”
The Forkhead Transcription Factor Foxo1 Regulates Adipocyte Differentiation
Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W. H., Arden, K. C., & Accili, D. (2003) · Developmental Cell · doi:10.1016/s1534-5807(02)00401-x · Cited by 727
Self-citationPhosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652
Self-citationNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Self-citationNakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Self-citation
Cited by
Items 601–700 of 1,000
Lipid and glucose metabolism in senescence
Liu, B., Meng, Q., Gao, X., Sun, H., Xu, Z., Wang, Y., & Zhou, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1157352 · Cited by 60
Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology
Eisele, P. S., & Handschin, C. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0406-4 · Cited by 61
“enhancer factor 2A (MEF2A), and MEF2C [22-26].”
Calabuig-Navarro, V., Yamauchi, J., Lee, S., Zhang, T., Liu, Y., Sadlek, K., Coudriet, G. M., Piganelli, J. D., Jiang, C., Miller, R., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.650994 · Cited by 56
“This effect is amplified by peroxisome proliferator-activated receptor coactivator 1- (PGC1 ) that acts as a co-activator of FoxO1 to enhance gluconeogenic activity in the liver (9).”
BackgroundSelf-citationAblation of PI3K p110-α Prevents High-Fat Diet–Induced Liver Steatosis
Chattopadhyay, M., Selinger, E. S., Ballou, L. M., & Lin, R. Z. (2011) · Diabetes · doi:10.2337/db10-0869 · Cited by 56
Yang, X., Nath, A., Opperman, M. J., & Chan, C. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-06-0481 · Cited by 56
“In healthy states, the low insulin level during fasting sustains the activity of FoxO1, which facilitates the transcription of key enzymes involved in gluconeogenesis (Puigserver et al., 2003).”
BackgroundMechanisms linking gut microbial metabolites to insulin resistance
Jang, H. R., & Lee, H. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.730 · Cited by 56
Wang, H., Peiris, T. H., Mowery, A., Le Lay, J., Gao, Y., & Greenbaum, L. E. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0388 · Cited by 52
Jaeger, D., Schoiswohl, G., Hofer, P., Schreiber, R., Schweiger, M., Eichmann, T. O., Pollak, N. M., Poecher, N., Grabner, G. F., Zierler, K. A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.035 · Cited by 56
Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis
Kim, K., Ryu, D., Dongiovanni, P., Ozcan, L., Nayak, S., Ueberheide, B., Valenti, L., Auwerx, J., & Pajvani, U. B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.039 · Cited by 51
Huang, J., Zhao, J., Geng, X., Chu, W., Li, S., Chen, Z., & Du, Y. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.12.008 · Cited by 55
“In addition, previous studies illustrated that FOXO1 mediates the metabolic consequences of insulin resistance.(28,29,72,73) Specifically, FOXO1 serves as the major intracellular transcription factor of insulin action and contributes to the regulation of glucose metabolism, including gluconeogenesis and glycolysis.”
MethodModular Evolution of PGC-1α in Vertebrates
LeMoine, C. M. R., Lougheed, S. C., & Moyes, C. D. (2010) · Journal of Molecular Evolution · doi:10.1007/s00239-010-9347-x · Cited by 59
“In contrast, the high variability of the region flanking the RNA recognition motif in fish may prevent interactions with other transcription factors, such as NRF-1 and FOXO1 associated with this area (Puigserver et al. 2003; Vercauteren et al. 2008).”
BackgroundRamin, N., Thieme, R., Fischer, S., Schindler, M., Schmidt, T., Fischer, B., & Santos, A. N. (2010) · Endocrinology · doi:10.1210/en.2010-0187 · Cited by 58
Wang, X., Wei, X., Pang, Q., & Yi, F. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.06.005 · Cited by 59
Effect of Ghrelin on Glucose-Insulin Homeostasis: Therapeutic Implications
Sangiao‐Alvarellos, S., & Cordido, F. (2010) · International Journal of Peptides · doi:10.1155/2010/234709 · Cited by 59
“PGC-1α hepatic transcription has been reported to be downregulated by AKT activation through forkhead transcription factor FOXO1 phosphorylation and nuclear exclusion [124].”
BackgroundForkhead box class O family member proteins: The biology and pathophysiological roles in diabetes
Tsuchiya, K., & Ogawa, Y. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12651 · Cited by 56
Sato, H., Hoshi, M., Ikeda, F., Fujiyuki, T., Yoneda, M., & Kai, C. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009841 · Cited by 54
Maissan, P., Mooij, E., & Barberis, M. (2021) · Biology · doi:10.3390/biology10030194 · Cited by 48
Wei, D., Tao, R., Zhang, Y., White, M. F., & Dong, X. C. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00524.2010 · Cited by 51
Rozance, P. J., Limesand, S. W., Barry, J. S., Brown, L. D., Wesolowski, S. R., LoTurco, D., Regnault, T. R. H., Friedman, J. E., & Hay, W. W. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00639.2007 · Cited by 53
PP2A inhibition results in hepatic insulin resistance despite Akt2 activation
Galbo, T., Perry, R. J., Nishimura, E., Samuel, V. T., Quistorff, B., & Shulman, G. I. (2013) · Aging · doi:10.18632/aging.100611 · Cited by 50
Li, X., Sui, Y., Wu, Q., Xie, B., & Sun, Z. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b00233 · Cited by 51
Signaling Network of Forkhead Family of Transcription Factors (FOXO) in Dietary Restriction
Jiang, Y.-Z., Yan, F., Feng, Z., Lazarovici, P., & Zheng, W. (2019) · Cells · doi:10.3390/cells9010100 · Cited by 56
Regulation of basal expression of hepatic PEPCK and G6Pase by AKT2
He, L., Li, Y., Zeng, N., & Stiles, B. L. (2020) · Biochemical Journal · doi:10.1042/bcj20190570 · Cited by 52
Insulin Regulation of Hepatic Lipid Homeostasis
Uehara, K., Santoleri, D., Whitlock, A. E. G., & Titchenell, P. M. (2023) · Comprehensive Physiology · doi:10.1002/cphy.c220015 · Cited by 49
Afzaal, A., Rehman, K., Kamal, S., & Akash, M. S. H. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23047 · Cited by 50
E47 modulates hepatic glucocorticoid action
Hemmer, M. C., Wierer, M., Schachtrup, K., Downes, M., Hübner, N., Evans, R. M., & Uhlenhaut, N. H. (2019) · Nature Communications · doi:10.1038/s41467-018-08196-5 · Cited by 53
Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin‐resistant hepatocytes
Chen, X., Chen, S., Shen, T., Yang, W., Chen, Q., Zhang, P., You, Y., Sun, X., Xu, H., Tang, Y., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000115rr · Cited by 51
Sun, X., Cao, Z., Ma, Y., Shao, Y., Zhang, J., Yuan, G., & Guo, X. (2020) · Food & Function · doi:10.1039/d0fo02387f · Cited by 54
Cloning of the Rat Pyruvate Dehydrogenase Kinase 4 Gene Promoter
Ma, K., Zhang, Y., Elam, M. B., Cook, G. A., & Park, E. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502236200 · Cited by 52
Peeters, A., Fraisl, P., van den Berg, S. A. A., van Themaat, E. V. L., van Kampen, A. H. C., Rider, M. H., Takemori, H., van Dijk, K. W., Veldhoven, P. P. V., Carmeliet, P., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.299727 · Cited by 61
Plum, L., Wunderlich, F. T., Baudler, S., Krone, W., & Brüning, J. C. (2005) · Physiology · doi:10.1152/physiol.00049.2004 · Cited by 64
Dietary ursolic acid improves health span and life span in male Drosophila melanogaster
Staats, S., Wagner, A. E., Lüersen, K., Künstner, A., Meyer, T., Kahns, A. K., Derer, S., Graspeuntner, S., Rupp, J., Busch, H., et al. (2019) · BioFactors · doi:10.1002/biof.1467 · Cited by 48
Darragh, I. A. J., O’Driscoll, L., & Egan, B. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.738333 · Cited by 55
de Souza, C. T., Frederico, M. J. S., da Luz, G., Cintra, D. E., Ropelle, E. R., Pauli, J. R., & Velloso, L. A. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2009.183996 · Cited by 62
“Foxo1 belongs to a nuclear protein subfamily (Kops et al. 1999; Nakae et al. 1999, 2001; Kaestner et al. 2000) and its phosphorylation blocks the expression of a number of genes involved in gluconeogenesis (Kops et al. 1999; Nakae et al. 1999; Puigserver et al. 2003).”
BackgroundTargeting PGC-1α to control energy homeostasis
Wu, Z., & Boss, O. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.10.1329 · Cited by 48
“Furthermore, induction of PGC-1 α in turn induces the expression of gluconeogenic genes expression by co-activating a number of transcription factors, most notably hepatocyte nuclear factor 4 α (HNF4 α ) and Forkhead box O1(Foxo1) [32,33] .”
BackgroundMitochondrial Biogenesis in Response to Chromium (VI) Toxicity in Human Liver Cells
Zhong, X., Sá, R. D. C. D. S. E., & Zhong, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091877 · Cited by 51
“showed that PGC-1α interacted with and co-activated FOXO1 in hepatocytes [33].”
BackgroundMaradonna, F., Polzonetti, V., Bandiera, S. M., Migliarini, B., & Carnevali, O. (2004) · Environmental Science & Technology · doi:10.1021/es049786h · Cited by 51
Acute exercise modulates the Foxo1/PGC‐1α pathway in the liver of diet‐induced obesity rats
Ropelle, E. R., Pauli, J. R., Cintra, D. E., Frederico, M. J. S., De Pinho, R. A., Velloso, L. A., & De Souza, C. T. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.164202 · Cited by 47
Polymorphisms in FOXO Gene Family and Association Analysis with BMI
Kim, J., Jung, H. S., Bae, S. W., Kim, J. H., Park, B. L., Choi, Y. H., Cho, H. Y., Cheong, H. S., & Shin, H. D. (2006) · Obesity · doi:10.1038/oby.2006.24 · Cited by 48
Kashiwagi, Y., Aburaya, S., Sugiyama, N., Narukawa, Y., Sakamoto, Y., Takahashi, M., Uemura, H., Yamashita, R., Tominaga, S., Hayashi, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97868-2 · Cited by 52
Madsen, L., & Kristiansen, K. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05262.x · Cited by 51
PPARγ activation attenuates glucose intolerance induced by mTOR inhibition with rapamycin in rats
Festuccia, W. T., Blanchard, P.-G., Belchior, T., Chimin, P., Paschoal, V. A., Magdalon, J., Hirabara, S. M., Simões, D., St-Pierre, P., Carpinelli, A., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00683.2013 · Cited by 46
Insulin-Loaded Microcapsules for In Vivo Delivery
Kim, B., Oh, J. M., Hyun, H., Kim, K. S., Lee, S. H., Kim, Y. H., Park, K., Lee, H. B., & Kim, M. S. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800087t · Cited by 51
The role of pathway-selective insulin resistance and responsiveness in diabetic dyslipoproteinemia
Wu, X., Chen, K., & Williams, K. J. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283544424 · Cited by 47
Kumar, A. A., Giri, S., & Shaha, C. (2018) · FEBS Journal · doi:10.1111/febs.14406 · Cited by 48
Insight into miRNAs related with glucometabolic disorder
Zhang, B., Shen, C., Zhu, B.-W., An, H., Zheng, B. J., Xu, S., Sun, J., Sun, P.-C., Zhang, W., Wang, J., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.123 · Cited by 49
Zhang, Y., Yan, L. S., Ding, Y., Cheng, B. C. Y., Luo, G., Kong, J., Liu, T. H., & Zhang, S. F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01666 · Cited by 50
Guo, X., Lin, H., Liu, J., Wang, D., Li, D., Jiang, C., Tang, Y., Wang, J., Zhang, T., Li, Y., et al. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108380 · Cited by 49
PGC1s and Beyond: Disentangling the Complex Regulation of Mitochondrial and Cellular Metabolism
Coppi, L., Ligorio, S., Mitro, N., Caruso, D., Fabiani, E. D., & Crestani, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136913 · Cited by 50
“Remarkably, the hepatic expression of this coactivator is highly boosted under conditions resembling obesity and diabetes [13,15,16] and this leads to higher glucose production by the liver, which contributes to the development of type 2 diabetes.”
BackgroundSong, S., Zhang, Y., Ma, K., Jackson‐Hayes, L., Lavrentyev, E. N., Cook, G. A., Elam, M. B., & Park, E. A. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2004.06.006 · Cited by 51
Finlay, D. K., Patel, S., Dickson, L. M., Shpiro, N., Márquez, R., Rhodes, C. J., & Sutherland, C. D. (2004) · BMC Molecular Biology · doi:10.1186/1471-2199-5-15 · Cited by 53
“linked to the regulation of the TIRE's found in these promoters [18,19].”
BackgroundExposure to dim light at night alters daily rhythms of glucose and lipid metabolism in rats
Rumanova, V. S., Okuliarová, M., Foppen, E., Kalsbeek, A., & Zeman, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.973461 · Cited by 52
Wang, G. Y., Qin, S. L., Zheng, Y. N., Geng, H., Chen, L., Yao, J. H., & Deng, L. (2023) · Animal nutrition · doi:10.1016/j.aninu.2023.07.001 · Cited by 50
“Several rate-limiting enzymes are involved in regulating the process of hepatic gluconeogenesis, including fructose 1,6-bisphosphatase (FBP1/2), cytosolic and mitochondrial phosphoenolpyruvate carboxykinase (PCK1/2), and glucose 6-phosphatase (G6PC) (Aschenbach et al., 2010; Pilkis et al., 1988; Pilkis and Granner, 19…”
BackgroundInfluentialThyroid hormone analogues and derivatives: Actions in fatty liver
Coppola, M. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i3.114 · Cited by 46
SIRT1 Disruption in Human Fetal Hepatocytes Leads to Increased Accumulation of Glucose and Lipids
Tobita, T., Guzman‐Lepe, J., Takeishi, K., Nakao, T., Wang, Y., Meng, F., Deng, C., de l’Hortet, A. C., & Soto–Gutiérrez, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149344 · Cited by 49
“Inhibition of SIRT1 leads to an increased gluconeogenesis in human fetal hepatocytes through the impairment of AKT/FOXO1 pathway Previous studies have reported controversial results regarding changes in glucose production and use in rodent models with SIRT1-knockout [10, 11].”
BackgroundInfluentialPonugoti, B., Fang, S., & Kemper, J. K. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0196 · Cited by 52
The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver
Oiso, H., Furukawa, N., Suefuji, M., Shimoda, S., Ito, A., Furumai, R., Nakagawa, J., Yoshida, M., Nishino, N., & Araki, E. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.086 · Cited by 47
“Among the complex network of transcription factors and cofactors that contribute to gluconeogenic gene expression in liver, the transcription factors cAMP responsive elementbinding protein (CREB), hepatocyte nuclear factor 4a (HNF4a) and forkhead box O 1 (FoxO1), and the coactivators peroxisome proliferators-activated…”
BackgroundUSP7 Attenuates Hepatic Gluconeogenesis Through Modulation of FoxO1 Gene Promoter Occupancy
Hall, J. A., Tabata, M., Rodgers, J. T., & Puigserver, P. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1420 · Cited by 45
Self-citationThe roles of FoxOs in modulation of aging by calorie restriction
Kim, D. H., Park, M. H., Lee, E. K., Choi, Y. J., Chung, K. W., Moon, K. M., Kim, M. J., An, H. J., Park, J. W., Kim, N. D., et al. (2014) · Biogerontology · doi:10.1007/s10522-014-9519-y · Cited by 50
“The co-activators include peroxisome proliferator-activated receptor gamma (PPAR-c) co-activator 1 alpha (PGC-1a) (Puigserver et al. 2003), CBP (van der Heide and Smidt 2005), and p300 (Perrot and Rechler 2005), Four and a half LIM 2 (FHL2) (Yang et al. 2005), b-catenin (Essers et al. 2005), and…”
BackgroundAttenuation of hepatic expression and secretion of selenoprotein P by metformin
Speckmann, B., Sies, H., & Steinbrenner, H. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.143 · Cited by 53
“As SeP is regulated virtually like a gluconeogenic enzyme by key hormones involved in the maintenance of plasma glucose homeostasis [16,17], we hypothesized a link between selenium and carbohydrate metabolism.”
BackgroundCollier, J. J., & Scott, D. K. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0357 · Cited by 48
“Furthermore, the transcription factor Foxo1, which is regulated by exclusion from the nucleus upon insulin signaling through phosphorylation by protein kinase B (Akt), also interacts with PGC-1 to stimulate gluconeogenesis (36).”
BackgroundReactive Oxygen Species Suppress Cardiac NaV1.5 Expression through Foxo1
Mao, W., You, T., Ye, B., Li, X., Dong, H. H., Hill, J. A., Li, F., & Xu, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032738 · Cited by 46
Self-citationHerzog, B., Hall, R. K., Wang, X. L., Waltner-Law, M., & Granner, D. K. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0384 · Cited by 44
Filippov, S. I., Pinkosky, S. L., & Newton, R. S. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000091 · Cited by 44
Agnoux, A. M., Antignac, J., Simard, G., Poupeau, G., Darmaun, D., Parnet, P., & Alexandre-Gouabau, M. C. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00015.2014 · Cited by 48
Insulin regulates menin expression, cytoplasmic localization, and interaction with FOXO1
Wuescher, L. M., Angevine, K., Hinds, T. D., Ramakrishnan, S. K., Najjar, S. M., & Mensah‐Osman, E. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00022.2011 · Cited by 47
Forkhead Box P1 (FOXP1) Transcription Factor Regulates Hepatic Glucose Homeostasis
Zou, Y., Gong, N., Cui, Y., Wang, X., Cui, A., Chen, Q., Jiao, T., Dong, X., Yang, H. Y., Zhang, S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.681627 · Cited by 46
“(7) previously showed that FOXO1 physically interacts with PGC-1 , synergistically stimulating expression of gluconeogenic genes, and insulin regulates PGC-1 function through inactivating FOXO1 activity.”
InfluentialSakai, M., Tujimura-Hayakawa, T., Yagi, T., Yano, H., Mitsushima, M., Unoki-Kubota, H., Kaburagi, Y., Inoue, H., Kido, Y., Kasuga, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13147 · Cited by 41
“PGC-1 a then functions with the transcription factors forkhead box O1 (FoxO1) 8 and hepatocyte nuclear factor–4 a (HNF-4 a ) 7,9 to mediate synergistic activation of the gluconeogenic program; however, how glucagon signalling triggers epigenetic changes for efficient transcription of gluconeogenic…”
de Paula, T. G., Zanella, B. T. T., Fantinatti, B. E. A., de Moraes, L. N., Duran, B. O. D. S., de Oliveira, C. B., Salomão, R. A. S., da Silva‐Gomes, R. N., Padovani, C. R., dos Santos, V. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177679 · Cited by 46
MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1
Luo, A., Yan, H., Liang, J., Du, C., Zhao, X., Sun, L., & Chen, Y. (2017) · Gene · doi:10.1016/j.gene.2017.06.024 · Cited by 44
“The activity of FOXO1 is modulated by post-translational modifications, including phosphorylation, acetylation and glycosylation [7, 11-14].”
BackgroundZhang, S., Li, P., Zhao, X., He, S., Xing, S., Cao, Z., Zhang, H., & Li, Z. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.131210 · Cited by 44
Komori, T., Tanaka, M., Senba, E., Miyajima, A., & Morikawa, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.542399 · Cited by 44
Kitazawa, M., Ohizumi, Y., Oike, Y., Hishinuma, T., & Hashimoto, S. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127530 · Cited by 48
“FoxO1 is expressed in the liver, where it can stimulate the expression of several genes promoting hepatic glucose production, including G6Pase, both in liver cells and in vivo (Puigserver et al., 2003).”
BackgroundOut of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis
Cheung, A. H. K., Hui, C. H., Wong, K. Y., Liu, X., Chen, B., Kang, W., & To, K. F. (2022) · International Journal of Cancer · doi:10.1002/ijc.34288 · Cited by 52
“The former would bind Forkhead box protein O1 (FOXO1) for further transcription of other gluconeogenesis genes.(84,85) The link between cell cycle regulators and gluconeogenesis has”
BackgroundRegulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators
Ramatchandirin, B., Pearah, A., & He, L. (2023) · Life · doi:10.3390/life13020515 · Cited by 48
Chiang, Y.-T. A., Shao, W., Xu, X. X., Chernoff, J., & Jin, T. (2012) · Endocrinology · doi:10.1210/en.2012-1781 · Cited by 47
Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk
Oladimeji, P. O., Cui, H., Zhang, C., & Chen, T. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1201069 · Cited by 44
“In addition, PGC-1α and FoxO1 are both glucagon sensors, and they could couple with each other to promote the expression of glycogenesis genes in human and mouse liver cells, which is blocked by insulin [137].”
BackgroundTsujimoto, S., Kishina, M., Koda, M., Yamamoto, Y., Tanaka, K., Harada, Y., Yoshida, A., & Hisatome, I. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2674 · Cited by 47
Dapagliflozin Aggravates Renal Injury via Promoting Gluconeogenesis in db/db Mice
Jia, Y., He, J., Wang, L., Su, L., Lei, L., Huang, W., Geng, X., Zhang, S., Meng, X., Zhou, H., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487783 · Cited by 44
Gao, N., Yao, X., Jiang, L., Yang, L., Qiu, T., Wang, Z., Pei, P., Yang, G., Liu, X., & Sun, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27318 · Cited by 48
“2019;234:5143–5152. wileyonlinelibrary.com/journal/jcp © 2018 Wiley Periodicals, Inc. | 5143 Abbreviations: 3‐MA, 3‐methyladenine; AUC, glucose area under the curve; FBPase, fructose‐1,6‐bisphosphatase; FOXO1, forkhead box protein O1; G6Pase, glucose‐6‐phosphatase; GK, glucokinase; GLUT2, glucose transporter type 2; G…”
BackgroundInfluentialLiao, K. L., Deng, S., Xu, L., Pan, W., Yang, S., Zheng, F., Wu, X., Hu, H., Liu, Z., Luo, J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2060 · Cited by 46
Silveira, W. A., Gonçalves, D. A. P., Machado, J., Lautherbach, N. E. S., Lustrino, D., Paula-Gomes, S., Pereira, M. G., Miyabara, E. H., Sandri, M., Kettelhut, Í. D. C., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902102rr · Cited by 49
Fang, X., Gao, G., Xue, H., Zhang, X., & Wang, H. (2012) · Toxicology · doi:10.1016/j.tox.2012.02.008 · Cited by 43
Hu, J., Jin, X., Kunikane, S., Terao, Y., & Aizawa, T. (2005) · Environmental Science & Technology · doi:10.1021/es0516108 · Cited by 43
Fanelli, M., Filippi, E., Sentinelli, F., Romeo, S., Fallarino, M., Buzzetti, R., Leonetti, F., & Baroni, M. G. (2005) · Disease Markers · doi:10.1155/2005/576748 · Cited by 52
da Rocha, A. L., Pereira, B. C., Pauli, J. R., Cintra, D. E., de Souza, C. T., Ropelle, E. R., & da Silva, A. S. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140020 · Cited by 43
Liver X Receptor: A Cardinal Target for Atherosclerosis and Beyond
Parikh, M., Patel, K. V., Soni, S., & Gandhi, T. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.19778 · Cited by 49
Vetterli, L., & Maechler, P. (2011) · Aging · doi:10.18632/aging.100304 · Cited by 51
D’Onofrio, N., Pieretti, G., Ciccarelli, F., Gambardella, A., Passariello, N., Rizzo, M. R., Barbieri, M., Marfella, R., Nicoletti, G., Balestrieri, M. L., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051153 · Cited by 43
Xie, Q., Peng, S., Tao, L., Ruan, H., Yang, Y., Li, T.-M., Adams, U., Meng, S., Bi, X., Dong, M.-Q., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.587170 · Cited by 42
“Additionally, the activity of FOXO can be modulated through direct binding to other proteins including PGC-1 and -catenin (31, 32).”
BackgroundNedumaran, B., Hong, S.-P., Xie, Y., Kim, Y., Seo, W., Lee, M., Lee, C. H., Koo, S., & Choi, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034660 · Cited by 47
Role of hepatic STAT3 in the regulation of lipid metabolism.
Kinoshita, S., Ogawa, W., Okamoto, Y., Takashima, M., Inoue, H., Matsuki, Y., Watanabe, E., Hiramatsu, R., & Kasuga, M. (2008) · PubMed · doi:10.24546/81000870 · Cited by 43
Mosaic analysis of insulin receptor function
Kitamura, T., Kitamura, Y., Nakae, J., Giordano, A., Cinti, S., Kahn, C. R., Efstratiadis, A., & Accili, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci17810 · Cited by 43
Self-citationLiška, F., Landa, V., Zídek, V., Mlejnek, P., Šilhavý, J., Šimáková, M., Strnad, H., Trnovská, J., Škop, V., Kazdová, L., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08798 · Cited by 42
Insulin Delivery Using Dynamic Covalent Boronic Acid/Ester‐Controlled Release
Banach, Ł., Williams, G. T., & Fossey, J. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100118 · Cited by 43
Li, F., Gao, J., Kohls, W., Geng, X., & Ding, Y. (2022) · Brain Circulation · doi:10.4103/bc.bc_27_22 · Cited by 42
“[44,45] FoxO1 transcriptionally regulates PCK in the pyruvate‐PEP futile cycle.[46] The resulting glucose reduction activates ER stress and it correspondingly regulates PCK2 mRNA.”
BackgroundPark, W., & Pak, Y. K. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.10.064 · Cited by 44
“In liver, FOXO1 augments hepatic glucose production through transcription of gluconeogenic genes, PEPCK and G6Pase (Puigserver et al., 2003), and suppresses glycolysis and lipogenesis by inhibiting expressions of glucokinase and SREBP-1c.”
BackgroundFoxO1 Links Hepatic Insulin Action to Endoplasmic Reticulum Stress
Kamagate, A., Kim, D. H., Zhang, T., Slusher, S., Gramignoli, R., Strom, S. C., Bertera, S., Ringquist, S., & Dong, H. H. (2010) · Endocrinology · doi:10.1210/en.2009-1306 · Cited by 42
Self-citationOuwens, D. M., & Diamant, M. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701422633 · Cited by 45
“…in the regulation of peroxisome proliferator activated receptor gamma coactivator 1 (PGC-1), acyl CoA oxidase (ACO), pyruvate dehy- drogenase kinase 4 (PDK4), and atrogin expression (Bastie et al., 2005; Daitoku et al., 2003; Furuyama et al., 2003; Puigserver et al., 2003; Skurk et al., 2005).”
BackgroundCollier, J. B., Whitaker, R. M., Eblen, S. T., & Schnellmann, R. G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.754762 · Cited by 47
Metadata
- Authors
- Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- Columbia University (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2003-05-18
- Volume
- 423
- Issue
- 6939
- Pages
- 550-555
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1583767403
- Cited by
- 1,487
- References
- 22
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 46 · 2023: 53 · 2022: 62 · 2021: 67 · 2020: 71 · 2019: 61 · 2018: 86 · 2017: 76 · 2016: 59 · 2015: 75 · 2014: 71 · 2013: 68 · 2012: 81
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Taiho Pharmaceutical
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Keywords
- hepatic gluconeogenesis, insulin signaling, FOXO1, PGC-1α, transcriptional coactivation, Akt phosphorylation, fasting, diabetes mellitus, glucocorticoids, glucagon, gluconeogenic gene expression, hepatocytes, forkhead transcription factor
- MeSH terms
- Forkhead Box Protein O1, Animals, Cells, Cultured, DNA-Binding Proteins, Gene Expression Regulation, Gluconeogenesis, Insulin, Liver, Precipitin Tests, Protein Binding, RNA, Messenger, Transcription Factors, Hepatocytes, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.